Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
C-MER RainsOptics is a Hong Kong-based medical device company focused on retinal imaging and eye-disease screening. The company develops smartphone-based ophthalmic diagnostic tools designed to help eye specialists and general practitioners perform retina examinations with portable, lower-cost equipment. Its lead product, Fundus Link, is a pocket smartphone ophthalmoscope/fundus camera intended to support diagnosis and screening for retinal and optic nerve disorders. The business appears to operate at the intersection of medtech, digital ophthalmology, and mobile health, with an emphasis on improving access to retinal care in resource-constrained settings. Founded by clinicians and engineers, the company positions its mission as making retina examination available "for everyone, everywhere."
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on C-MER RainsOptics.